tiprankstipranks
Quanterix Corporation (QTRX)
NASDAQ:QTRX
US Market

Quanterix (QTRX) Earnings Dates, Call Summary & Reports

Compare
349 Followers

Earnings Data

Report Date
May 13, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.43
Last Year’s EPS
-0.26
Same Quarter Last Year
Based on 4 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 17, 2025
|
% Change Since: -8.52%
|
Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
Quanterix demonstrated strong growth in revenue and margins, supported by strategic investments and expansion efforts. However, challenges in the academic market and specific regional declines present notable headwinds. The overall sentiment is balanced with both positive growth indicators and concerns about near-term market volatility.
Company Guidance
During the Quanterix Corporation Fourth Quarter 2024 Earnings Call, the company reported several key metrics and provided guidance for 2025. The company achieved revenue of $35.2 million in Q4 2024, marking an 11% increase from the previous year, with the Accelerator lab contributing $8.6 million, a 22% growth. Quanterix’s non-GAAP gross margin improved by 300 basis points year-over-year to 57.7%, driven by higher pricing and improved operational efficiency. Cash usage declined by 31% to $4.4 million in the fourth quarter. For the full year 2024, total revenue was $137.4 million, up 12%. Looking forward to 2025, Quanterix expects revenue to range between $140 million and $146 million, with GAAP gross margin anticipated between 59% and 63%, and non-GAAP gross margin between 53% and 57%. The company plans to invest approximately $30 million in diagnostics and the Simoa ONE platform, which is expected to launch at the end of 2025. Quanterix also announced a merger agreement with Akoya Biosciences, aimed at expanding their addressable market and achieving $40 million in operating synergies by 2026.
Seventh Consecutive Quarter of Double-Digit Revenue Growth
Quanterix reported its seventh consecutive quarter of double-digit revenue growth, with a total revenue of $35.2 million, marking an 11% increase year-over-year.
Strong Performance in Accelerator Lab
The Accelerator lab revenue grew by 22% in the quarter, driven by capacity expansion and strong demand for clinical trials and custom assay development.
Non-GAAP Gross Margin Improvement
Non-GAAP gross margin improved by 300 basis points to 57.7% in the fourth quarter, driven by higher pricing and improved operating efficiency.
Significant Expansion in Recurring Revenues
Recurring revenues increased from 65% to 80% over two years, contributing to a revenue CAGR of 14%.
Acquisition of Akoya Biosciences
The planned acquisition of Akoya Biosciences is expected to expand Quanterix's research addressable market from $1 billion to $5 billion, and diagnostics TAM from $10 billion to $15 billion.
---

Quanterix (QTRX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

QTRX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 20252025 (Q1)
-0.43 / -
-0.26
Mar 17, 20252024 (Q4)
-0.26 / -0.30
-0.339.09% (+0.03)
Nov 12, 20242024 (Q3)
-0.24 / -0.22
-0.21-4.29% (>-0.01)
Aug 08, 20242024 (Q2)
-0.27 / -0.25
-0.16-56.25% (-0.09)
May 07, 20242024 (Q1)
-0.31 / -0.26
-0.16-62.50% (-0.10)
Feb 29, 20242023 (Q4)
-0.31 / -0.33
-0.534.00% (+0.17)
Nov 06, 20232023 (Q3)
-0.37 / -0.21
-0.9577.89% (+0.74)
Aug 07, 20232023 (Q2)
-0.38 / -0.16
-0.6776.12% (+0.51)
May 09, 20232023 (Q1)
-0.38 / -0.16
-0.4967.35% (+0.33)
Mar 06, 20232022 (Q4)
-0.47 / -0.50
-0.5468.42% (+0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

QTRX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 17, 2025$7.28$7.15-1.79%
Nov 12, 2024$15.17$12.40-18.26%
Aug 08, 2024$12.82$10.92-14.82%
May 07, 2024$17.36$16.51-4.90%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Quanterix Corporation (QTRX) report earnings?
Quanterix Corporation (QTRX) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
    What is Quanterix Corporation (QTRX) earnings time?
    Quanterix Corporation (QTRX) earnings time is at May 13, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is QTRX EPS forecast?
          QTRX EPS forecast for the fiscal quarter 2025 (Q1) is -0.43.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis